The preserved extracellular matrix provides structural proteins and aligned, native three-dimensional pathways that can guide regenerating axons across a nerve gap. This architecture supplies directional organization that is difficult to reproduce with an unstructured material. In bioengineering, maintaining these pathways is therefore central to retaining the graft’s regenerative guidance function after cellular components have been removed.
Effective processing must disrupt and wash out cellular membranes, nuclei, and other immunogenic components without substantially damaging the extracellular matrix, alignment, or mechanical properties. Excessive treatment may compromise the structural features needed for guidance and handling, whereas incomplete processing may leave unwanted cellular material. This balance determines whether the resulting graft remains both biologically useful and structurally functional.
Their main distinction is the retention of tissue-derived architecture, including native extracellular matrix organization and aligned conduits. Synthetic conduits do not originate from donor nerve tissue, while decellularized grafts offer a clinically relevant biological alternative. The comparison is not simply biological versus artificial: graft performance depends on how processing preserves guidance and mechanical properties, as well as how each option suits nerve-gap repair.
Chemical, enzymatic, or physical treatments can be used to disrupt cellular membranes and nuclei and then wash out the resulting cellular material. These approaches are selected and controlled according to the need to remove immunogenic components while preserving extracellular matrix structure and native pathways. The processing workflow therefore focuses on both effective decellularization and protection of the scaffold’s regenerative features.
Bioengineers can use these grafts to bridge gaps in damaged peripheral nerves, where an aligned tissue-derived scaffold may support axonal regeneration. They may also combine the graft with Schwann cells, stem cells, or other biomaterials to improve regenerative performance. Such designs use the graft as a biologically organized framework while adding cellular or material components intended to enhance repair.
Evaluation should consider whether cellular and immunogenic components were removed while structural proteins, aligned pathways, and suitable mechanical properties were retained. These features determine how well the graft can provide directional support and function as a bridge across a nerve gap. In bioengineering studies, they also help assess whether added Schwann cells, stem cells, or biomaterials can be integrated effectively.